StreetInsider.com News Articles

Form 6-K Innate Pharma SA For: Sep 10

Thu, 10 Sep 2026 06:29:00 -0400

si-local-file:///var/storage/secattach/20260910/27044751.html

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

Thu, 10 Sep 2026 01:00:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT, to provide a business update for the first half of 2026.

Participants in the call will be:

Jonathan Dickinson, Chief Executive Officer
Markus Jensen, Vice President, Chief Medical Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event Details

Date and time: September 17, 2026, at 2:00 p.m. CEST / 8:00 a.m. EDT
Webcast link:

Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update

Thu, 10 Sep 2026 01:00:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants in the call will be:

Jonathan Dickinson, Chief Executive Officer
Markus Jensen, Vice President, Chief Medical Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer

Event Details

Date and time: September 17, 2026, at 2:00 p.m. CEST / 8:00 a.m. EDT
Webcast link:

Form 6-K Innate Pharma SA For: Aug 19

Wed, 19 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260819/26949960.html

Form 6-K Innate Pharma SA For: Aug 19

Wed, 19 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260819/26949960.html

Form 6-K Innate Pharma SA For: Aug 19

Wed, 19 Aug 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260819/26949960.html

Form 6-K Innate Pharma SA For: Aug 14

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924046.html

Form 6-K Innate Pharma SA For: Aug 14

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924046.html

Form 6-K Innate Pharma SA For: Aug 14

Fri, 14 Aug 2026 06:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26924046.html

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Friday, August 14, 2026 at 2:00 p.m. CEST / 8:00 a.m. EDT.

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma Announces Conference Call and Webcast

Fri, 14 Aug 2026 05:30:00 -0400

MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News:

Participants during the call will be:

Jonathan Dickinson, Chief Executive Officer
Yannis Morel, Executive Vice President, Chief Operating Officer
Frédéric Lombard, Senior Vice President, Chief Financial Officer
Stéphanie Cornen, Vice President, Investor Relations, Communication

Event Details

The live webcast will be available at the following link:
https://events.q4inc.com/attendee/322508798

Participants may also join via telephone using the following registration link:

Innate Pharma S.A. (IPHA) PT Raised to $9 at BTIG

Tue, 11 Aug 2026 16:02:32 -0400

BTIG analyst Jeet Mukherjee raised the price target on Innate Pharma S.A. (NASDAQ: IPHA) to $9.00 (from $8.00) while maintaining a Buy rating.

Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright

Tue, 11 Aug 2026 06:52:59 -0400

(Updated - August 11, 2026 6:52 AM EDT)

H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Innate Pharma S.A. (NASDAQ: IPHA) to $7.00 (from $5.00) while maintaining a Buy rating.

The analyst commented: "On August 10, Innate Pharma announced a strategic partnership with Swedish Orphan Biovitrum (STO:SOBI; Buy; Kapoor) to license lacutamab, an anti-KIR3DL2 antibody in late-stage development for cutaneous T-cell lymphoma (CTCL). Recall that enrollment of TELLOMAK-3, the confirmatory Phase 3 trial, was the gating event for Innate's ability to pursue accelerated approval. The agreement is structured to enable initiation of confirmatory Phase 3 study TELLOMAK-3 and the subsequent

Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright

Tue, 11 Aug 2026 06:52:59 -0400

(Updated - August 11, 2026 6:52 AM EDT)

H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Innate Pharma S.A. (NASDAQ: IPHA) to $7.00 (from $5.00) while maintaining a Buy rating.

Leerink Upgrades Innate Pharma S.A. (IPHA) to Outperform

Tue, 11 Aug 2026 06:11:56 -0400

Leerink analyst Daina Graybosch upgraded Innate Pharma S.A. (NASDAQ: IPHA) from Market Perform to Outperform with a price target of $4.00.

For an analyst ratings summary and ratings history on Innate Pharma S.A. click here. For more ratings news on Innate Pharma S.A. click here.

Shares of Innate Pharma S.A. closed at $2.22 yesterday.

Form 6-K Innate Pharma SA For: Aug 10

Mon, 10 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260810/26893649.html

Form 6-K Innate Pharma SA For: Aug 10

Mon, 10 Aug 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260810/26893649.html